Resveratrol Inhibits Activation of Microglia after Stroke through Triggering Translocation of Smo to Primary Cilia
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Activated microglia act as a double-edged sword for stroke. In the acute phase of stroke, activated microglia might deteriorate neurological function. Therefore, it is of great clinical transforming potential to explore drugs or methods that can inhibit abnormal activation of microglia in the acute phase of stroke to improve neurological function after stroke. Resveratrol has a potential effect of regulating microglial activation and anti-inflammation. However, the molecular mechanism of resveratrol-inhibiting microglial activation has not been fully clarified. Smoothened (Smo) belongs to the Hedgehog (Hh) signaling pathway. Smo activation is the critical step that transmits the Hh signal across the primary cilia to the cytoplasm. Moreover, activated Smo can improve neurological function via regulating oxidative stress, inflammation, apoptosis, neurogenesis, oligodendrogenesis, axonal remodeling, and so on. More studies have indicated that resveratrol can activate Smo. However, it is currently unknown whether resveratrol inhibits microglial activation via Smo. Therefore, in this study, N9 microglia in vitro and mice in vivo were used to investigate whether resveratrol inhibited microglial activation after oxygen-glucose deprivation/reoxygenation (OGD/R) or middle cerebral artery occlusion/reperfusion (MCAO/R) injury and improved functional outcome via triggering translocation of Smo in primary cilia. We definitively found that microglia had primary cilia; resveratrol partially inhibited activation and inflammation of microglia, improved functional outcome after OGD/R and MCAO/R injury, and triggered translocation of Smo to primary cilia. On the contrary, Smo antagonist cyclopamine canceled the above effects of resveratrol. The study suggested that Smo receptor might be a therapeutic target of resveratrol for contributing to inhibit microglial activation in the acute phase of stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This understanding has been recently updated by findings that demonstrate the presence of primary cilia on microglia (Liao et al., 2023; Yeo et al., 2023).”
From Primary cilia in the mature brain: emerging roles in Alzheimer's disease pathogenesis (2025) · cites this paper as Liao et al., 2023
The cited source says what the claim attributes to it.
In the citing paper
“However, Liao et al. showed that N9 microglia possess primary cilium marked by acetylated α-tubulin (Liao et al. 2023).”
From Changes of the Primary Cilia in Alzheimer's Disease Pathogenesis (2025) · cites this paper as Liao et al. 2023
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463 · cited 1×
“Neurologic deficit scores were analyzed at 3 d after MCAO with Longa score [33], modified Bederson score [34], and modified Neurological Severity Score (mNSS) [35] by an independent investigator in a blinded fashion.”
MethodBederson, J. B., Pitts, L. H., Tsuji, M., Nishimura, M. C., Davis, R. L., & Bartkowski, H. (1986) · Stroke · doi:10.1161/01.str.17.3.472 · Cited by 2,681 · cited 1×
“Neurologic deficit scores were analyzed at 3 d after MCAO with Longa score [33], modified Bederson score [34], and modified Neurological Severity Score (mNSS) [35] by an independent investigator in a blinded fashion.”
MethodChen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., & Chopp, M. (2001) · Stroke · doi:10.1161/01.str.32.4.1005 · Cited by 1,764 · cited 1×
“Neurologic deficit scores were analyzed at 3 d after MCAO with Longa score [33], modified Bederson score [34], and modified Neurological Severity Score (mNSS) [35] by an independent investigator in a blinded fashion.”
MethodThe mechanisms of Hedgehog signalling and its roles in development and disease
Briscoe, J., & Thérond, P. P. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3598 · Cited by 1,751 · cited 3×
“Smo activation is the critical step that transmits the Hh signal across the primary cilia to the cytoplasm, ultimately resulting in the activation of the glioma-associated oncogene family members (Gli) transcription factors [22,23].”
BackgroundMicroglia in neurodegeneration
Hickman, S., Izzy, S., Sen, P., Morsett, L., & El Khoury, J. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0242-x · Cited by 1,710 · cited 1×
“Microglia, resident immune cells in the central nervous system, play a local immune surveillance role and are involved in the modulation of the brain’s inflammatory response [1].”
BackgroundThe Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Potential Adverse Effects of Resveratrol: A Literature Review
Shaito, A., Posadino, A. M., Younes, N., Hasan, H., Halabi, S., Alhababi, D., Al-Mohannadi, A., Abdel-Rahman, W. M., Eid, A. H., Nasrallah, G. K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062084 · Cited by 716 · cited 1×
“Many literatures have reported that resveratrol has beneficial and harmful effects based on the characteristics of the enrolled patients, the doses used, duration of resveratrol supplementation, the environment stayed, and so on [6,36].”
BackgroundAnti-Inflammatory Action and Mechanisms of Resveratrol
Meng, T., Xiao, D., Muhammed, A., Deng, J., Chen, L., & He, J. (2021) · Molecules · doi:10.3390/molecules26010229 · Cited by 698 · cited 1×
“Resveratrol is a naturally occurring polyphenolic phytoalexin extracted from dietary sources such as grapes, mulberries, polygonum cuspidatum, semen cassiae, peanuts, and red wine [4].”
BackgroundThe biphasic function of microglia in ischemic stroke
Ma, Y., Wang, J., Wang, Y., & Yang, G.-Y. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.005 · Cited by 655 · cited 5×
“In the LPS/IFN-γ-treated N9 microglia, resveratrol attenuated microglial activation via SIRT1-SOCS1 pathway [14].”
BackgroundInfluentialMechanisms and functions of Hedgehog signalling across the metazoa
Ingham, P. W., Nakano, Y., & Seger, C. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2984 · Cited by 605 · cited 1×
“Smo activation is the critical step that transmits the Hh signal across the primary cilia to the cytoplasm, ultimately resulting in the activation of the glioma-associated oncogene family members (Gli) transcription factors [22,23].”
Background
Cited by
A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke
Owjfard, M., Rahimian, Z., Karimi, F., Borhani‐Haghighi, A., & Mallahzadeh, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34121 · Cited by 50
“Studies have found that the Smo receptor could be a therapeutic target of resveratrol, assisting to decrease microglial activity in the acute phase of stroke [79].”
BackgroundCalabrese, V., Osakabe, N., Siracusa, R., Modafferi, S., Paola, R. D., Cuzzocrea, S., Jacob, U. M., Fritsch, T., Abdelhameed, A. S., Rashan, L. J., et al. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111960 · Cited by 17
Rhoa/ROCK, mTOR and Secretome-Based Treatments for Ischemic Stroke: New Perspectives
Pinoșanu, E. A., Pîrșcoveanu, D. F. V., Albu, C. V., Burada, E., Pîrvu, A., Surugiu, R., Sandu, R. E., & Serb, A. F. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040219 · Cited by 15
“A different study proposed that the Smoothened (Smo) receptor could be a therapeutic target of resveratrol in order to help decrease microglial activity during the initial stage of a stroke [102].”
BackgroundYang, J., Ma, Y., Yang, L., Li, P., Li, P. A., Li, P. A., & Zhang, J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321006 · Cited by 16
“The rats were anesthetized with 1–3% isoflurane and then the MCAO/R model was established as previously described following hyperglycemia induction for 4 weeks [26].”
Primary cilia in the mature brain: emerging roles in Alzheimer's disease pathogenesis
Huang, A. S., Li, A. S. M., & Hor, C. H. H. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1650884 · Cited by 6
Changes of the Primary Cilia in Alzheimer's Disease Pathogenesis
Guo, A., Wang, H., Zhang, Y., & Huang, H. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70125 · Cited by 7
“However, Liao et al. showed that N9 microglia possess primary cilium marked by acetylated α-tubulin (Liao et al. 2023).”
Sonic Hedgehog pathway: molecular mechanisms and therapeutic potentials in ischemic stroke recovery
Yan, M., Yang, S., Zhao, B., & Ning, T. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117235 · Cited by 3
van Rooij, J. R. A., van den Berg, M., Vosselen, M. V., Calus, E., Vasilkovska, T., Kosten, L., Spilbeeck, I. V., Audekerke, J. V., Dam, D. V., Bertoglio, D., et al. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115647 · Cited by 2
Mechanical regulation of microenvironment remodeling in brain tumors: from mechanism to therapy
Fan, H., Xu, C., He, S., Wang, J., Zhu, H., & Shu, K. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03857-5 · Cited by 3
“In microglia, they have been implicated in regulating microglial activation, neuroinflammation and phagocytosis [101, 102], and it is plausible that cilia-mediated mechanotransduction contributes to these processes, although this has not yet been directly confirmed.”
Self-citationImplicating clinical utility of altered expression of PTCH1 & SMO in oral squamous cell carcinoma
Patel, H. V., Joshi, J. S., & Shah, F. D. (2024) · Journal of Molecular Histology · doi:10.1007/s10735-024-10215-3 · Cited by 2
“The cytoplasmic accumulation of cytoplasmic SMO was observed in a study comprising of N9 microglial cells, where the translocation of SMO to primary cilium from cytoplasm takes place for Hh pathway activation (Liao et al. 2023).”
Chen, Y., Zhang, W., Sun, Q., Wang, X., Shang, Q., Liu, J., Zhang, Y., Liu, R., & Sun, C. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101143 · Cited by 2
Self-citationPolyphenol effects in pathologies related to cerebral stroke
Romero-Bernal, M., González-Díaz, Á., Nájar, A. M., del Río, C., & Montaner, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13821-8.00006-8
El-Din, A. A., Tahoon, D. M., Elmaaboud, M. A. A., Elmonem, F. F. A., & Abdin, A. A. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117681
Gu, C., Bostani, A., & Wang, H. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04717-7
Mesaoudi, A. E. (2024) · theses.fr (ABES) · doi:10.70675/f339157ez1688z4acaz87fcz0ecae062a7cc
Kaplanis, S. I., Spyridakos, D., Zyganitidis, I., Lygeraki, A., Kaffe, D., Georgilis, A., Ieremiadis, V., Petsangouraki, S., Theodorakis, Κ., Savvaki, M., et al. (2026) · Glial health research. · doi:10.1016/j.ghres.2026.100016
Wang, T., Tzeng, I., Chen, Y.-C., & Chen, M. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48070694
“Several phytochemicals help repress microglial overactivation and prevent neuronal overactivity, thereby avoiding excessive neuroinflammation and neuronal injury [96,97].”
Self-citationResveratrol and Curcumin in Stroke Therapy: From Experimental Evidence to Clinical Perspectives
Grabarczyk, M., Szychowska, A., Szczepańska, W., Smolińska, E., Glabinski, A. R., & Szpakowski, P. (2026) · Nutrients · doi:10.3390/nu18162713 · Cited by 1
Song, M., Bu, N., Wei, L., & Chen, J. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1945478
“Acute SMO-dependent restraint of microglial activation further supports phase-specific regulation of phagocyte state (Liao et al., 2023).”
Metadata
- Authors
- Liao, H., Huang, J., Liu, J., Chen, Y., Zhu, H., Li, X., Wen, J., Xiang, Q., & Yang, Q.
- Affiliations
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Department of Neurology, Longevity District People’s Hospital of Chongqing, Chongqing 401220, China
- Corresponding author
- Yang, Qin
- Venue
- Journal of Personalized Medicine
- Publisher
- MDPI AG
- Published
- 2023-01-31
- Volume
- 13
- Issue
- 2
- Pages
- 268
- ISSN
- 2075-4426 (ISSN-L)
- PMC
- PMC9961736
- OpenAlex
- W4318777709
- Cited by
- 19
- References
- 55
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 6
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Personalized Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81671309, 81971229, XZ2017ZR-ZY026, CYS17148)
- Tibet Nature Science Foundation of Tibet (81671309, 81971229, XZ2017ZR-ZY026, CYS17148)
- Postgraduate Research and Innovation Project of Chongqing (81671309, 81971229, XZ2017ZR-ZY026, CYS17148)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- resveratrol, microglial activation, stroke, Smoothened receptor, Hedgehog signaling, primary cilia, cyclopamine, oxygen-glucose deprivation/reoxygenation, middle cerebral artery occlusion/reperfusion, neuroinflammation, neuroprotection, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.